123 related articles for article (PubMed ID: 6840685)
1. Cholic acid amelioration of light and electron microscopic hepatic lesions in experimental protoporphyria.
Lefkowitch JH; Feng-Chen KC; Sklar JA; Poh-Fitzpatrick MB
Hepatology; 1983; 3(3):399-406. PubMed ID: 6840685
[TBL] [Abstract][Full Text] [Related]
2. Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.
Poh-Fitzpatrick MB; Sklar JA; Goldsman C; Lefkowitch JH
J Clin Invest; 1983 Oct; 72(4):1449-58. PubMed ID: 6630515
[TBL] [Abstract][Full Text] [Related]
3. Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
Berenson MM; Welch V; Garcia-Marin JJ
J Lab Clin Med; 1991 Jul; 118(1):89-98. PubMed ID: 2066649
[TBL] [Abstract][Full Text] [Related]
4. Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
Choi SW; Han JH; Lim KT; Cho HM; Chung KW; Sun HS; Park DH; Kim BS; Seo EJ
J Korean Med Sci; 1991 Jun; 6(2):146-56. PubMed ID: 1751019
[TBL] [Abstract][Full Text] [Related]
5. [Experimental protoporphyria induced by griseofulvin. II. Effects of cholic acid ingestion in griseofulvin-induced protoporphyria mice].
Irifune H
Nihon Hifuka Gakkai Zasshi; 1988 Nov; 98(12):1177-82. PubMed ID: 3230643
[No Abstract] [Full Text] [Related]
6. Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment.
Rademakers LH; Cleton MI; Kooijman C; Baart de la Faille H; van Hattum J
Hepatology; 1990 Mar; 11(3):449-57. PubMed ID: 2312057
[TBL] [Abstract][Full Text] [Related]
7. Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals.
Gschnait F; Konrad K; Hönigsmann H; Denk H; Wolff K
J Invest Dermatol; 1975 Sep; 65(3):290-9. PubMed ID: 1159316
[TBL] [Abstract][Full Text] [Related]
8. Bile secretion and liver microsomal mixed function oxidase system in mice with griseofulvin-induced hepatic protoporphyria.
Cantoni L; Di Padova C; Rovagnati P; Ruggieri R; Dal Fiume D; Tritapepe R
Toxicology; 1983 May; 27(1):27-39. PubMed ID: 6679936
[TBL] [Abstract][Full Text] [Related]
9. Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver.
Avner DL; Lee RG; Berenson MM
J Clin Invest; 1981 Feb; 67(2):385-94. PubMed ID: 7462423
[TBL] [Abstract][Full Text] [Related]
10. [Hepatic reactions in erythropoietic protoporphyria (author's transl)].
Klinge O; Alexandrakis E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 37(3):369-79. PubMed ID: 6117981
[TBL] [Abstract][Full Text] [Related]
11. An autopsy case of erythropoietic protoporphyria with cholestatic jaundice and hepatic failure, and a review of literature.
Nakanuma Y; Wada M; Kono N; Miyamura H; Ohta G
Virchows Arch A Pathol Anat Histol; 1981; 393(2):123-32. PubMed ID: 7292974
[TBL] [Abstract][Full Text] [Related]
12. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding.
McCullough AJ; Barron D; Mullen KD; Petrelli M; Park MC; Mukhtar H; Bickers DR
Gastroenterology; 1988 Jan; 94(1):177-81. PubMed ID: 3335288
[TBL] [Abstract][Full Text] [Related]
13. Formation of biliary thrombi in protoporphyrin-induced cholestasis in perfused rat liver.
Berenson MM; Gunther C; Samowitz WS; Bjorkman DJ
Hepatology; 1990 May; 11(5):757-63. PubMed ID: 2347550
[TBL] [Abstract][Full Text] [Related]
14. [Reversibility of griseofulvin induced protoporphyria in the mice].
Irifune H
Nihon Hifuka Gakkai Zasshi; 1987 Jun; 97(7):801-4. PubMed ID: 3669397
[No Abstract] [Full Text] [Related]
15. A light and electron microscopic study of the liver in case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice.
Matilla A; Molland EA
J Clin Pathol; 1974 Sep; 27(9):698-709. PubMed ID: 4372253
[TBL] [Abstract][Full Text] [Related]
16. Chenodeoxycholic acid therapy in erythrohepatic protoporphyria.
Van Hattum J; Baart de la Faille H; Van den Berg JW; Edixhoven-Bosdijk A; Wilson JH
J Hepatol; 1986; 3(3):407-12. PubMed ID: 3559148
[TBL] [Abstract][Full Text] [Related]
17. [The influence of ursodesoxycholic acid (URSO) on griseofulvin (GF)-induced protoporphyria].
Irifune H; Tsukazaki N; Watanabe M; Nonaka S
Nihon Hifuka Gakkai Zasshi; 1991 Jul; 101(8):813-7. PubMed ID: 1942584
[TBL] [Abstract][Full Text] [Related]
18. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity.
Miyata M; Tozawa A; Otsuka H; Nakamura T; Nagata K; Gonzalez FJ; Yamazoe Y
J Pharmacol Exp Ther; 2005 Feb; 312(2):759-66. PubMed ID: 15466244
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of protoporphyrins in erythropoietic protoporphyria and griseofulvin-induced murine protoporphyria. Binding affinities, distribution, and fluorescence spectra in various blood fractions.
Poh-Fitzpatrick MB; Lamola AA
J Clin Invest; 1977 Aug; 60(2):380-9. PubMed ID: 874098
[TBL] [Abstract][Full Text] [Related]
20. Experimental murine protoporphyria induced by griseofulvin (GF): the relationship between hepatic porphyrin levels and liver function test values in mice treated with GF.
Tanaka K; Ohgami T; Nonaka S
J Dermatol; 1993 Sep; 20(9):545-53. PubMed ID: 8227709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
